Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Non-Current Deferred Tax Liability (2018 - 2024)

Ptc Therapeutics has reported Non-Current Deferred Tax Liability over the past 7 years, most recently at $55.9 million for Q3 2024.

  • Quarterly results put Non-Current Deferred Tax Liability at $55.9 million for Q3 2024, up 7.67% from a year ago — trailing twelve months through Sep 2024 was $55.9 million (up 7.67% YoY), and the annual figure for FY2023 was $55.9 million, down 45.64%.
  • Non-Current Deferred Tax Liability for Q3 2024 was $55.9 million at Ptc Therapeutics, roughly flat from $55.9 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for PTCT hit a ceiling of $137.1 million in Q4 2021 and a floor of $51.9 million in Q3 2023.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $130.9 million (2020), compared with a mean of $105.6 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: increased 12.39% in 2022 and later tumbled 62.13% in 2023.
  • Ptc Therapeutics' Non-Current Deferred Tax Liability stood at $136.7 million in 2020, then grew by 0.27% to $137.1 million in 2021, then dropped by 25.0% to $102.8 million in 2022, then tumbled by 45.64% to $55.9 million in 2023, then grew by 0.01% to $55.9 million in 2024.
  • The last three reported values for Non-Current Deferred Tax Liability were $55.9 million (Q3 2024), $55.9 million (Q2 2024), and $55.9 million (Q1 2024) per Business Quant data.